Fig. 3. PXRD patterns of (A) pure dazomet, (B) pure hexaconazole, (C) chitosan, and chitosan–hexaconazole–dazomet nanoparticles prepared at various concentrations of TPP (D) 2.5 mg mL⁻¹, (E) 5 mg mL⁻¹, (F) 10 mg mL⁻¹ and (G) 20 mg mL⁻¹.